During the past decade, McGill University, Dept. Oncology Clinical Research Program conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 4 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "McGill University, Dept. Oncology Clinical Research Program" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "McGill University, Dept. Oncology Clinical Research Program" are "Anemia" (1 trials), "Breast Cancer" (1 trials), "Leukemia, Myeloid, Acute" (1 trials), "Myelodysplastic Syndrome" (1 trials) and "Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction" (1 trials). Many other conditions were trialed in "McGill University, Dept. Oncology Clinical Research Program" in a lesser frequency.

Most popular intervention types in "McGill University, Dept. Oncology Clinical Research Program" are "Drug" (5 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Capecitabine" (2 trials), "Oral Azacitidine" (2 trials), "5-Fluorouracil" (1 trials) and "Avelumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "McGill University, Dept. Oncology Clinical Research Program" are 5 trials for "All" genders.

Currently, there are NaN active trials in "McGill University, Dept. Oncology Clinical Research Program". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in McGill University, Dept. Oncology Clinical Research Program, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in McGill University, Dept. Oncology Clinical Research Program, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".